Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines
Ninecia R. Scott, Beth Mann, Elaine Tuomanen, et al.
Vaccines (2021) Vol. 9, Iss. 3, pp. 209-209
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The remarkable history of pneumococcal vaccination: an ongoing challenge
Daniel M. Musher, Ronald Anderson, Charles Feldman
Pneumonia (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 66
A conserved antigen induces respiratory Th17-mediated broad serotype protection against pneumococcal superinfection
Xue Liu, Laurye Van Maele, Laura Matarazzo, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 3, pp. 304-314.e8
Open Access | Times Cited: 9
Streptococcus pneumoniae serotype distribution in low- and middle-income countries of South Asia: Do we need to revisit the pneumococcal vaccine strategy?
Priya Dhawale, Sanket Shah, Kaushal Sharma, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains
Mona Shafaghi, Zohreh Bahadori, Hamid Madanchi, et al.
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 21
Recent progress in pneumococcal protein vaccines
Sha Li, Hangeri Liang, S Zhao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines
Qianqian Du, Wei Shi, Dan Yu, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 12, pp. 5628-5637
Open Access | Times Cited: 32
A Jack of All Trades: The Role of Pneumococcal Surface Protein A in the Pathogenesis of Streptococcus pneumoniae
Jessica Lane, Muralidhar Tata, David E. Briles, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 21
In-silico design and evaluation of an epitope-based serotype-independent promising vaccine candidate for highly cross-reactive regions of pneumococcal surface protein A
Elnaz Afshari, Reza Ahangari Cohan, Fattah Sotoodehnejadnematalahi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Expression Purification and Immunogenicity Detection of HtsA + FtsB Fusion Protein From Streptococcus pyogenes
Jing Li, Yan Ju, Min Jiang, et al.
Microbiology and Immunology (2025)
Closed Access
A bacterial vesicle-based pneumococcal vaccine against influenza-mediated secondary Streptococcus pneumoniae pulmonary infection
Saugata Majumder, Peng Li, Shreya Das, et al.
Mucosal Immunology (2024) Vol. 17, Iss. 2, pp. 169-181
Open Access | Times Cited: 3
Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study
Yanxia Wang, Gang Shi, Xue Wang, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 827-827
Open Access | Times Cited: 3
Yields and Immunomodulatory Effects of Pneumococcal Membrane Vesicles Differ with the Bacterial Growth Phase
Mina Mehanny, Tobias Kroniger, Marcus Koch, et al.
Advanced Healthcare Materials (2021) Vol. 11, Iss. 5
Open Access | Times Cited: 20
PspA-mediated aggregation protects Streptococcus pneumoniae against desiccation on fomites
Jessica Lane, Muralidhar Tata, Rahena Yasmin, et al.
mBio (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 7
Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines
Ruiying Wang, Lorena V. N. Oliveira, Maureen M. Hester, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Protection against experimental cryptococcosis elicited by Cationic Adjuvant Formulation 01-adjuvanted subunit vaccines
Ruiying Wang, Lorena V. N. Oliveira, Maureen M. Hester, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 7, pp. e1012220-e1012220
Open Access | Times Cited: 1
Analysis of Immunobiological Properties of Recombinant Streptococcus pneumoniae Pneumolysin
D. S. Vorobyev, Е. С. Петухова, Yu. V. Volokh, et al.
Bulletin of Experimental Biology and Medicine (2024) Vol. 177, Iss. 2, pp. 248-251
Closed Access | Times Cited: 1
Challenges for the human immune system after leaving Earth
Shannon Marchal, Alexander Choukèr, Jürgen Bereiter‐Hahn, et al.
npj Microgravity (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
A conserved antigen induces respiratory Th17-mediated serotype-independent protection against pneumococcal superinfection
Xue Liu, Laurye Van Maele, Laura Matarazzo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Development of a bivalent protein-based vaccine candidate against invasive pneumococcal diseases based on novel pneumococcal surface protein A in combination with pneumococcal histidine triad protein D
Elnaz Afshari, Reza Ahangari Cohan, Mohammad Sadegh Shams Nosrati, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Intranasal bivalent vaccine with recombinant Influenza Virus expressing Pneumococcal Surface Protein A (PspA) protects against Streptococcus pneumoniae and Influenza A virus infection in mice
Márcio Sobreira Silva Araújo, Kimberly Cardoso, Lara Alves de Souza, et al.
Research Square (Research Square) (2024)
Open Access
Pneumolysin-responsive liposomal platform for selective treatment of Streptococcus pneumoniae
Ethan Watt, Ilinca Andriescu, Emmanuel A. Ho
Drug Delivery and Translational Research (2024)
Closed Access
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections
Kimberly Cardoso, Lara Regina Alves de Souza, Beatriz Senra Álvares da Silva Santos, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Multi epitope vaccine candidate design againstStreptococcus pneumonia
Yogeshwar Devarakonda, M. V. N. Janaradhan Reddy, R. S. Neethu, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 12654-12667
Closed Access | Times Cited: 1
Correlation of Human Microbiome and Immune Functioning with COVID-19 Infections: An Overview
Purnima Khatri, Asha Rani, Ramendra Pati Pandey, et al.
(2023), pp. 195-216
Closed Access
Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines
Keith P. Klugman, Richard Malley, Cynthia G. Whitney
Elsevier eBooks (2023), pp. 826-868.e18
Closed Access
Page 1 - Next Page

Scroll to top